Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Heying Pei

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-induced B-Cell Acute Lymphoblastic Leukemia

Clinical Cancer Research

Cancer Research

English